
HHS proposes 90-day MU attestation period, easier patient engagement
HHS proposes shortening the Meaningful Use reporting period to 90 days in 2015, cutting the "view, download, transmit" requirement to a single patient.
HHS proposes shortening the Meaningful Use reporting period to 90 days in 2015, cutting the "view, download, transmit" requirement to a single patient.
My 83 year old father-in-law returned from a recent outpatient visit to his primary care provider with two customized handouts – a transition of care summary detailing problems/meds/allergies and an opt-in consent for the exchange of that care summary over the state Healthcare Information Exchange, the MassHIWay. We discussed them over dinner. A photo is […]
See how Quantum Health is providing the steps to help their members tackle the cost of specialty medications and other drugs.
CMS Proposed Rule Creates Meaningful Use Confusion We have entered Zombie Land. The 2011 Edition of certified technology was put to rest on December 31, 2013. The nails were put in the coffin. We said our goodbyes, made our peace, and tried to move on. Now without warning a CMS Proposed Rule threatens to bring […]
Under stage 2 of Meaningful Use, patient and family access to data sources will be required. This will prevent the confusion that resulted in my mom being prescribed 22 medications during a recent hospital stay for a broken hip.
Last week, I participated in the ITDotHealth Conference in Boston, discussing one simple question with a selection of the nation’s EHR and PHR experts : How we can best innovate/change our EHRs while also operating them to transact daily patient care? Here’s what I suggested. 1. Federal Meaningful Use Stage 3 is likely to include […]
if you’re building software in the health IT world, you should be jumping into MU Stage 2 requirements in earnest now and start your programming engines as soon as possible.
FASENRA® (benralizumab) injection, for subcutaneous use, 30 mg is indicated for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis (EGPA). FASENRA provides a treatment option for HCPs to consider when managing this challenging disease.
As I've written in previous posts, MU 2 is truly a work of art and the stakeholder response to it has been very positive. There are a few persistent questions about the MU program that are worth sharing with the community.
Jeff Rowe, editor of The Health Record Review is unhappy that the government will impose penalties for providers who do not achieve Meaningful Use of electronic health records. His hypothesis: penalties are there only because policymakers want to “exercise their inner regulators” and that therefore the penalties should be dropped. He ends his piece with […]
First it was on, then it was off and finally in the afternoon, the government published Stage 2 requirements for meaningful use of electronic health records. Here are early reactions.
So the holidays have past and we can all ease back into the well-known and comfortable understanding of Stage 1 Meaningful Use and incentives. Correct? Well don’t get too deep in that couch. Sure the incentives are flying into inboxes at a record pace. In November 2011 alone over $585,000,000 was paid out to Eligible Professionals and Eligible Hospitals as incentives. I hope […]
Help shape the future of healthcare benefits by sharing your insights.
Stage 2 Meaningful Use for Eligible Professionals and Eligible Hospitals looks a long way off. We are still out of breath from climbing the rock face to Stage 1 Meaningful Use and most EPs and EHs are still climbing. Maybe it is time to find a plateau, refill our water canteens and gain our bearings. […]